| Cardiovascular effects of Urtica dioica L.(Urticaceae) roots extracts: in vitro and in vivo pharmacological studies L Testai, S Chericoni, V Calderone, G Nencioni, P Nieri, I Morelli, ... Journal of Ethnopharmacology 81 (1), 105-109, 2002 | 227 | 2002 |
| Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels V Calderone, S Chericoni, C Martinelli, L Testai, A Nardi, I Morelli, ... Naunyn-Schmiedeberg's archives of pharmacology 370, 290-298, 2004 | 193 | 2004 |
| Hydrogen sulphide: novel opportunity for drug discovery A Martelli, L Testai, MC Breschi, C Blandizzi, A Virdis, S Taddei, ... Medicinal research reviews 32 (6), 1093-1130, 2012 | 179 | 2012 |
| Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo A Martelli, L Testai, V Citi, A Marino, I Pugliesi, E Barresi, G Nesi, ... ACS medicinal chemistry letters 4 (10), 904-908, 2013 | 156 | 2013 |
| Large-conductance, Ca2+-activated K+ channels: function, pharmacology and drugs V Calderone Current medicinal chemistry 9 (14), 1385-1395, 2002 | 152 | 2002 |
| (+/−)‐Naringenin as large conductance Ca2+‐activated K+ (BKCa) channel opener in vascular smooth muscle cells S Saponara, L Testai, D Iozzi, E Martinotti, A Martelli, S Chericoni, ... British journal of pharmacology 149 (8), 1013-1021, 2006 | 144 | 2006 |
| Nutraceutical value of citrus flavanones and their implications in cardiovascular disease L Testai, V Calderone Nutrients 9 (5), 502, 2017 | 129 | 2017 |
| Synthesis and β-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano [2, 3-b] pyridine: Potential antihypertensive agents … PL Ferrarini, C Mori, M Badawneh, V Calderone, R Greco, C Manera, ... European journal of medicinal chemistry 35 (9), 815-826, 2000 | 129 | 2000 |
| Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels A Martelli, L Testai, MC Breschi, K Lawson, NG McKay, F Miceli, ... Pharmacological research 70 (1), 27-34, 2013 | 127 | 2013 |
| Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts L Testai, A Martelli, M Cristofaro, MC Breschi, V Calderone Journal of Pharmacy and Pharmacology 65 (5), 750-756, 2013 | 113 | 2013 |
| Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition M Bucci, V Vellecco, A Cantalupo, V Brancaleone, Z Zhou, S Evangelista, ... Cardiovascular research 102 (1), 138-147, 2014 | 103 | 2014 |
| Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels LDC Mannelli, E Lucarini, L Micheli, I Mosca, P Ambrosino, MV Soldovieri, ... Neuropharmacology 121, 49-59, 2017 | 101 | 2017 |
| Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae? V Citi, A Martelli, L Testai, A Marino, MC Breschi, V Calderone Planta medica 80 (08/09), 610-613, 2014 | 98 | 2014 |
| Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? A Martelli, L Testai, V Citi, A Marino, FG Bellagambi, S Ghimenti, ... Vascular pharmacology 60 (1), 32-41, 2014 | 97 | 2014 |
| The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury L Testai, A Martelli, A Marino, V D’antongiovanni, F Ciregia, L Giusti, ... Biochemical pharmacology 85 (11), 1634-1643, 2013 | 96 | 2013 |
| Proposal of a new binding orientation for non-peptide AT1 antagonists: Homology modeling, docking and three-dimensional quantitative structure− activity relationship analysis T Tuccinardi, V Calderone, S Rapposelli, A Martinelli Journal of medicinal chemistry 49 (14), 4305-4316, 2006 | 89 | 2006 |
| Mitochondrial potassium channels as pharmacological target for cardioprotective drugs L Testai, S Rapposelli, A Martelli, MC Breschi, V Calderone Medicinal Research Reviews 35 (3), 520-553, 2015 | 83 | 2015 |
| Synthesis of 1, 8-naphthyridine derivatives: Potential antihypertensive agents—Part VII PL Ferrarini, C Mori, M Badawneh, V Calderone, L Calzolari, T Loffredo, ... European journal of medicinal chemistry 33 (5), 383-397, 1998 | 81 | 1998 |
| New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties MC Breschi, V Calderone, M Digiacomo, M Macchia, A Martelli, ... Journal of medicinal chemistry 49 (8), 2628-2639, 2006 | 76 | 2006 |
| 1, 5-Diarylsubstituted 1, 2, 3-triazoles as potassium channel activators. VI G Biagi, V Calderone, I Giorgi, O Livi, E Martinotti, A Martelli, A Nardi Il Farmaco 59 (5), 397-404, 2004 | 76 | 2004 |
